As of 2026-06-15, the Relative Valuation of Apellis Pharmaceuticals Inc (APLS) is 16.49 USD. This relative valuation is based on P/E multiples. With the latest stock price at 41.03 USD, the upside of Apellis Pharmaceuticals Inc based on Relative Valuation is -59.8%.
The range of the Relative Valuation is 5.91 - 27.48 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.3x - 26.4x | 25.4x |
| Forward P/E multiples | 22.1x - 27.2x | 24.6x |
| Fair Price | 5.91 - 27.48 | 16.49 |
| Upside | -85.6% - -33.0% | -59.8% |
| Date | P/E |
| 2026-05-13 | 39.41 |
| 2026-05-12 | 39.44 |
| 2026-05-11 | 39.40 |
| 2026-05-08 | 39.41 |
| 2026-05-07 | 39.39 |
| 2026-05-06 | 39.50 |
| 2026-05-05 | 39.36 |
| 2026-05-04 | 39.36 |
| 2026-05-01 | 39.35 |
| 2026-04-30 | 39.34 |
| 2026-04-29 | 39.34 |
| 2026-04-28 | 39.38 |
| 2026-04-27 | 39.34 |
| 2026-04-24 | 39.33 |
| 2026-04-23 | 39.33 |
| 2026-04-22 | 39.28 |
| 2026-04-21 | 39.33 |
| 2026-04-20 | 39.33 |
| 2026-04-17 | 39.29 |
| 2026-04-16 | 39.26 |
| 2026-04-15 | 39.24 |
| 2026-04-14 | 39.24 |
| 2026-04-13 | 39.23 |
| 2026-04-10 | 39.18 |
| 2026-04-09 | 39.05 |
| 2026-04-08 | 39.09 |
| 2026-04-07 | 39.10 |
| 2026-04-06 | 39.03 |
| 2026-04-02 | 38.82 |
| 2026-04-01 | 38.80 |
| 2026-03-31 | 38.65 |
| 2026-03-30 | 16.42 |
| 2026-03-27 | 16.30 |
| 2026-03-26 | 16.95 |
| 2026-03-25 | 17.02 |
| 2026-03-24 | 16.55 |
| 2026-03-23 | 16.88 |
| 2026-03-20 | 16.53 |
| 2026-03-19 | 17.26 |
| 2026-03-18 | 17.19 |